Co-administration of temozolomide (TMZ) and the experimental therapeutic targeting miR-10b, profoundly affects the tumorigenic phenotype of human glioblastoma cells
Introduction: Recent studies have shown that miRNA-10b is highly expressed in high-grade glioblastoma multiforme (GBM), and its inhibition leads to deregulation of multiple pathways in tumorigenesis, resulting in repression of tumor growth and increased apoptosis. Thus, we hypothesized that suppress...
| Published in: | Frontiers in Molecular Biosciences |
|---|---|
| Main Authors: | Ming Chen, Bryan Kim, Neil Robertson, Sujan Kumar Mondal, Zdravka Medarova, Anna Moore |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-06-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2023.1179343/full |
Similar Items
Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes
by: Marcin Jezierzański, et al.
Published: (2024-07-01)
by: Marcin Jezierzański, et al.
Published: (2024-07-01)
Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide
by: Lu-Ting Kuo, et al.
Published: (2017-01-01)
by: Lu-Ting Kuo, et al.
Published: (2017-01-01)
De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells
by: Megan Pitz, et al.
Published: (2022-09-01)
by: Megan Pitz, et al.
Published: (2022-09-01)
Development of Angiopep-2 targeted dendrimer-based nanotheranostic system for enhanced temozolomide delivery to glioblastoma multiforme
by: Ashish Kumar Parashar, et al.
Published: (2025-02-01)
by: Ashish Kumar Parashar, et al.
Published: (2025-02-01)
Glioblastoma Multiforma Tedavisinde Kanser Kök Hücrelerinin Temozolomide Karşı Oluşturdukları Direnç
by: Meryem Alagoz
Published: (2018-06-01)
by: Meryem Alagoz
Published: (2018-06-01)
Temozolomide-associated blepharoconjunctivitis: a case report
by: Tom Kornhauser, et al.
Published: (2024-04-01)
by: Tom Kornhauser, et al.
Published: (2024-04-01)
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
by: Jiao Meng, et al.
Published: (2024-03-01)
by: Jiao Meng, et al.
Published: (2024-03-01)
Molecular Docking and Molecular Dynamics Studies Reveal Secretory Proteins as Novel Targets of Temozolomide in Glioblastoma Multiforme
by: Sumera, et al.
Published: (2022-10-01)
by: Sumera, et al.
Published: (2022-10-01)
The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma multiforme: a meta-analysis and systematic review
by: Ehsan Alimohammadi, et al.
Published: (2020-02-01)
by: Ehsan Alimohammadi, et al.
Published: (2020-02-01)
Exploratory Study on Nanoparticle Co-Delivery of Temozolomide and Ligustilide for Enhanced Brain Tumor Therapy
by: Gang Ke, et al.
Published: (2025-02-01)
by: Gang Ke, et al.
Published: (2025-02-01)
Radiosensitizing properties of dual-functionalized carbon nanostructures loaded with temozolomide
by: Radmila Milenkovska, et al.
Published: (2025-02-01)
by: Radmila Milenkovska, et al.
Published: (2025-02-01)
Delta-radiomics Entropy Based on Tumor Heterogeneity Concept – Response Predictor to Irradiation for Unresectable/recurrent Glioblastoma
by: Camil Ciprian MIRESTEAN, et al.
Published: (2022-12-01)
by: Camil Ciprian MIRESTEAN, et al.
Published: (2022-12-01)
Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation
by: Madineh Mazarei, et al.
Published: (2021-06-01)
by: Madineh Mazarei, et al.
Published: (2021-06-01)
TRPC5 mediates TMZ resistance in TMZ-resistant glioblastoma cells via NFATc3-P-gp pathway
by: Yan Zou, et al.
Published: (2021-12-01)
by: Yan Zou, et al.
Published: (2021-12-01)
Unusual presentation of glioblastoma in the brainstem: a case report of a diffuse pontine glioblastoma multiforme and surgical management
by: Brandon Edelbach, et al.
Published: (2024-03-01)
by: Brandon Edelbach, et al.
Published: (2024-03-01)
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
by: Jun-Hai Tang, et al.
Published: (2019-12-01)
by: Jun-Hai Tang, et al.
Published: (2019-12-01)
Importance of Autophagy Regulation in Glioblastoma with Temozolomide Resistance
by: Young Keun Hwang, et al.
Published: (2024-08-01)
by: Young Keun Hwang, et al.
Published: (2024-08-01)
Investigating the Stability of Six Phenolic TMZ Ester Analogues, Incubated in the Presence of Porcine Liver Esterase and Monitored by HPLC
by: Leroy A. Shervington, et al.
Published: (2022-05-01)
by: Leroy A. Shervington, et al.
Published: (2022-05-01)
Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors
by: Supriya Mallick, et al.
Published: (2015-01-01)
by: Supriya Mallick, et al.
Published: (2015-01-01)
Temozolomide Resistance in Glioblastoma by NRF2: Protecting the Evil
by: Karoline Almeida Lima, et al.
Published: (2023-04-01)
by: Karoline Almeida Lima, et al.
Published: (2023-04-01)
The Role of Progranulin (PGRN) in the Pathogenesis of Glioblastoma Multiforme
by: Łukasz A. Poniatowski, et al.
Published: (2024-01-01)
by: Łukasz A. Poniatowski, et al.
Published: (2024-01-01)
Repurposing of CNS accumulating drugs Gemfibrozil and Doxylamine for enhanced sensitization of glioblastoma cells through modulation of autophagy
by: Smita Dey, et al.
Published: (2025-07-01)
by: Smita Dey, et al.
Published: (2025-07-01)
Molecular Mechanisms of KDELC2 on Glioblastoma Tumorigenesis and Temozolomide Resistance
by: Yu-Ling Tsai, et al.
Published: (2020-09-01)
by: Yu-Ling Tsai, et al.
Published: (2020-09-01)
RETRACTED: LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
by: Qing Zhang, et al.
Published: (2020-10-01)
by: Qing Zhang, et al.
Published: (2020-10-01)
Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
by: Hee Yeon Kim, et al.
Published: (2019-10-01)
by: Hee Yeon Kim, et al.
Published: (2019-10-01)
A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches
by: Meijun Liu, et al.
Published: (2025-06-01)
by: Meijun Liu, et al.
Published: (2025-06-01)
Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma
by: Zongze He, et al.
Published: (2024-05-01)
by: Zongze He, et al.
Published: (2024-05-01)
[Cost-Effectiveness Analysis of TTFields with TMZ Versus TMZ in Monotherapy in Patients with Grade 4 Glioma in Italy]
by: Ippazio Cosimo Antonazzo, et al.
Published: (2025-10-01)
by: Ippazio Cosimo Antonazzo, et al.
Published: (2025-10-01)
SB365, <i>Pulsatilla</i> Saponin D Induces Caspase-Independent Cell Death and Augments the Anticancer Effect of Temozolomide in Glioblastoma Multiforme Cells
by: Jun-Man Hong, et al.
Published: (2019-09-01)
by: Jun-Man Hong, et al.
Published: (2019-09-01)
Substituted Caffeic and Ferulic Acid Phenethyl Esters: Synthesis, Leukotrienes Biosynthesis Inhibition, and Cytotoxic Activity
by: Pier Morin, et al.
Published: (2017-07-01)
by: Pier Morin, et al.
Published: (2017-07-01)
Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma
by: Susanne Flor, et al.
Published: (2021-12-01)
by: Susanne Flor, et al.
Published: (2021-12-01)
Synergistic effect of perampanel with temozolomide on glioblastoma cells in vivo
by: Takuma Nishide, et al.
Published: (2025-03-01)
by: Takuma Nishide, et al.
Published: (2025-03-01)
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
by: Mahsa Palizkaran Yazdi, et al.
Published: (2024-07-01)
by: Mahsa Palizkaran Yazdi, et al.
Published: (2024-07-01)
Considering the Experimental Use of Temozolomide in Glioblastoma Research
by: Verena J. Herbener, et al.
Published: (2020-06-01)
by: Verena J. Herbener, et al.
Published: (2020-06-01)
TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma
by: Jian Yu, et al.
Published: (2022-07-01)
by: Jian Yu, et al.
Published: (2022-07-01)
Radiotherapy in Glioblastoma Multiforme: Evolution, Limitations, and Molecularly Guided Future
by: Castalia Fernández, et al.
Published: (2025-09-01)
by: Castalia Fernández, et al.
Published: (2025-09-01)
Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction
by: Supriya Mallick, et al.
Published: (2015-01-01)
by: Supriya Mallick, et al.
Published: (2015-01-01)
Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
by: Evrim Metcalfe, et al.
Published: (2016-08-01)
by: Evrim Metcalfe, et al.
Published: (2016-08-01)
Comparison of multi-cycle and standard-cycle temozolomide chemotherapies in patients with glioblastoma undergoing surgery and successive radiotherapy
by: Yuan Fu, et al.
Published: (2023-06-01)
by: Yuan Fu, et al.
Published: (2023-06-01)
Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells
by: Samantha L. Gerlach, et al.
Published: (2024-09-01)
by: Samantha L. Gerlach, et al.
Published: (2024-09-01)
Similar Items
-
Temozolomide (TMZ) in the Treatment of Glioblastoma Multiforme—A Literature Review and Clinical Outcomes
by: Marcin Jezierzański, et al.
Published: (2024-07-01) -
Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide
by: Lu-Ting Kuo, et al.
Published: (2017-01-01) -
De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells
by: Megan Pitz, et al.
Published: (2022-09-01) -
Development of Angiopep-2 targeted dendrimer-based nanotheranostic system for enhanced temozolomide delivery to glioblastoma multiforme
by: Ashish Kumar Parashar, et al.
Published: (2025-02-01) -
Glioblastoma Multiforma Tedavisinde Kanser Kök Hücrelerinin Temozolomide Karşı Oluşturdukları Direnç
by: Meryem Alagoz
Published: (2018-06-01)
